Literature DB >> 11430423

Use of alternative/complementary therapy in breast cancer patients--a psychological perspective.

R Moschèn1, G Kemmler, H Schweigkofler, B Holzner, M Dünser, R Richter, W W Fleischhacker, B Sperner-Unterweger.   

Abstract

The objectives of this study were to assess the additional use of alternative (complementary) therapies in patients with breast cancer who were receiving conventional treatment and to compare patients using alternative therapies with patients receiving only conventional treatment with special reference to psychological adaptation, causal attribution and quality of life. A sample of 117 female out-patients with a diagnosis of breast cancer filled in the following assessment instruments: FQCI (Freiburg Questionnaire for Coping with Illness), PUK (Causal Attribution Questionnaire), EORTC QLQ-C30 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire), POMS (Profile of Mood States), and a self-developed questionnaire on alternative therapies. Nearly half the patients (47%, n = 55) reported that they had used alternative therapies in addition to conventional treatment. The methods applied most frequently were nutrition-related measures (special drinks, vitamin preparations and whole-foods - each applied by about 50% of users), mistletoe preparations (49%), trace elements (47%), and homeopathy (31%). Compared with patients receiving only conventional treatment, the users of alternative therapy were younger and better educated. Users developed a more active style of illness coping than nonusers and showed more religious involvement. Patients using a large number of alternative therapies (>3) tended to adopt a more depressive coping style than those using only a small number (< or =3). For a substantial proportion of cancer patients alternative therapies apparently fulfil an important psychological need. However, a subgroup of patients using many alternative therapies seem to have considerable adjustment problems. In dealing with cancer patients the treatment team should be aware of both these groups.

Entities:  

Mesh:

Year:  2001        PMID: 11430423     DOI: 10.1007/s005200000208

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  25 in total

1.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

2.  Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Authors:  Annett Apel; Brigitte Greim; Nicolaus König; Uwe K Zettl
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

3.  Demographic, medical, and psychosocial correlates to CAM use among survivors of colorectal cancer.

Authors:  Catalina Lawsin; Katherine DuHamel; Steven H Itzkowitz; Karen Brown; Helen Lim; Linda Thelemaque; Lina Jandorf
Journal:  Support Care Cancer       Date:  2007-01-05       Impact factor: 3.603

Review 4.  Complementary and alternative medicine and coping in neuroimmunological diseases.

Authors:  A Apel; B Greim; U K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

5.  Predictors of yoga use among patients with breast cancer.

Authors:  Krupali Desai; Marjorie A Bowman; Mary Lou Galantino; Chanita Hughes-Halbert; Neha Vapiwala; Angela Demichele; Jun J Mao
Journal:  Explore (NY)       Date:  2010 Nov-Dec       Impact factor: 1.775

6.  Complementary and alternative medicine use in breast cancer patients in Europe.

Authors:  Alexander Molassiotis; Julia A Scott; Nora Kearney; Dorit Pud; Miriam Magri; Sarka Selvekerova; Ingrid Bruyns; Paz Fernadez-Ortega; Vassiliki Panteli; Anita Margulies; Gudbjorg Gudmundsdottir; Ljiljana Milovics; Gulten Ozden; Nurgun Platin; Elisabeth Patiraki
Journal:  Support Care Cancer       Date:  2005-09-06       Impact factor: 3.603

7.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

8.  Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey.

Authors:  G Nagel; H Hoyer; D Katenkamp
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

9.  Discrepant views of oncologists and cancer patients on complementary/alternative medicine.

Authors:  Mary Ann Richardson; Louise C Mâsse; Kelly Nanny; Christina Sanders
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

10.  Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador).

Authors:  R Ziegler; Ronald Grossarth-Maticek
Journal:  Evid Based Complement Alternat Med       Date:  2008-04-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.